In conclusion, our meta-analysis has shown that the initiation of treatment at the prediabetic stage, whether with either GLP-1 RA or SGLT-2i, shows promising evidence in delaying the onset of type 2 diabetes diagnosis. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.